Interferon alpha-2b biosimilar - Laboratorio Varifarma

Drug Profile

Interferon alpha-2b biosimilar - Laboratorio Varifarma

Alternative Names: Interferon alfa 2b Cassara; Interferón alfa 2b recombinante humano

Latest Information Update: 04 Mar 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Laboratorio Varifarma
  • Developer Laboratorio Pablo Cassara; Laboratorio Varifarma
  • Class Antineoplastics; Antivirals; Interferons
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer; Condylomata acuminata; Hepatitis B; Hepatitis C

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
  • 04 Mar 2014 Launched prior to this date for Cancer in Argentina (Parenteral)
  • 04 Mar 2014 Launched prior to this date for Condylomata acuminata in Argentina (Intralesional)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top